Table 2.
Characteristics of STEMI patients at presentation in Dhaka, Bangladesh (August 2017–October 2018)
| Characteristics | MACE n = 80 | Without MACE n = 521 | p value |
|---|---|---|---|
| Symptoms n (%) | |||
| Chest discomfort | 78 (97.5) | 505 (96.9) | 0.780 |
| Dyspnea | 41 (51.3) | 181 (34.7) | 0.004 |
| Sweating | 63 (78.8) | 413 (79.3) | 0.915 |
| Nausea | 43 (53.8) | 245 (47.0) | 0.262 |
| Vomiting | 31 (38.8) | 197 (37.8) | 0.872 |
| Fainting | 6 (7.5) | 29 (5.6) | 0.492 |
| Troponin I level at admissiona | |||
| Mean Troponin I, ng/ml (SD) | 37.3 (43.4) | 19.4 (33.7) | 0.002 |
| Not elevated, n (%) | 2 (2.5) | 30 (5.8) | Ref |
| Elevated, n (%) | 27 (33.8) | 138 (26.6) | 0.157 |
| Not available, n (%) | 51 (63.8) | 353 (67.8) | – |
| Location of STEMI n (%) | |||
| Anterior | 25 (31.3) | 140 (26.9) | Ref |
| Anteroseptal | 10 (12.5) | 79 (15.2) | 0.383 |
| Inferior | 36 (45.0) | 247 (47.4) | 0.467 |
| Lateral | 2 (2.5) | 9 (1.7) | 0.775 |
| Other | 7 (8.8) | 46 (8.8) | 0.718 |
Theh bold font was used to indicate that the value is statistically significant, i.e. p < 0.005
an = 197 subjects had Troponin I level assessed